Subscribe

What are you looking for?

Main Menu

明報新聞網

港產生物醫學初創智和生物 與中科院達成技術轉讓協議

Future Wealths
Future Wealths
5 11 月, 2025
One Min Read
3 Views
0 Comments
香港大學李嘉誠醫學院有份資助的本地生物科技初創「智和生物科技」（ZERO Biotech）今日宣布，與中國科學院上海藥物研究所（中科院）達成技術轉讓協議，將引進中科院在 FAPI（纖維母細胞活化蛋白抑制劑）基礎上的最新分子技術，用於開發「診療一體化」的新型核藥物。

原文: https://finance.mingpao.com/fin/instantf/20251105/1762336023200/%e6%b8%af%e7%94%a2%e7%94%9f%e7%89%a9%e9%86%ab%e5%ad%b8%e5%88%9d%e5%89%b5%e6%99%ba%e5%92%8c%e7%94%9f%e7%89%a9-%e8%88%87%e4%b8%ad%e7%a7%91%e9%99%a2%e9%81%94%e6%88%90%e6%8a%80%e8%a1%93%e8%bd%89%e8%ae%93%e5%8d%94%e8%ad%b0

Last Update: 5 11 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept